Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information - shares
6 Months Ended
Jun. 30, 2021
Jul. 22, 2021
Document Information Line Items    
Entity Registrant Name Lantern Pharma Inc.  
Trading Symbol LTRN  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   11,184,039
Amendment Flag false  
Entity Central Index Key 0001763950  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Jun. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity Incorporation, State or Country Code DE  
Entity File Number 001-39318  
Entity Tax Identification Number 46-3973463  
Entity Address, Address Line One 1920 McKinney Avenue  
Entity Address, Address Line Two 7th Floor  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75201  
City Area Code 972  
Local Phone Number 277-1136  
Title of 12(b) Security Common Stock, $0.0001 par value  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes